↓ Skip to main content

Nebulized glycyrrhizin/enoxolone drug modulates IL-17A in COVID-19 patients: a randomized clinical trial

Overview of attention for article published in Frontiers in immunology, January 2024
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
4 Mendeley